“Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial”. J. Neurol. Neurosurg. Psychiatry. (April 2018). doi:10.1136/jnnp-2018-317964. PMID29666206.
“The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis”. Biol Trace Elem Res150 (1-3): 42–8. (December 2012). doi:10.1007/s12011-012-9487-5. PMID22895810.
“Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache”. Cochrane Database Syst Rev (12): CD005219. (December 2015). doi:10.1002/14651858.CD005219.pub3. PMID26709672.
“High-flow oxygen therapy for treatment of acute migraine: A randomized crossover trial”. Cephalalgia37 (8): 730–736. (July 2017). doi:10.1177/0333102416651453. PMID27206964.
“Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial”. Am J Emerg Med30 (9): 1760–4. (November 2012). doi:10.1016/j.ajem.2012.02.010. PMID22560101.
“Migraine is a risk factor for sudden sensorineural hearing loss: a nationwide population-based study”. Cephalalgia33 (2): 80–6. (January 2013). doi:10.1177/0333102412468671. PMID23197354.
“Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders”. Int. J. Neuropsychopharmacol.14 (1): 123–30. (February 2011). doi:10.1017/S1461145710000805. PMID20633320.
“A study of oxidative stress in migraine with special reference to prophylactic therapy”. Int. J. Neurosci.128 (4): 318–324. (April 2018). doi:10.1080/00207454.2017.1374959. PMID28903615.
“Oxidative stress in the airways of children with asthma and allergic rhinitis”. Pediatr Allergy Immunol23 (6): 556–61. (September 2012). doi:10.1111/j.1399-3038.2012.01294.x. PMID22435922.
“Increased expression of lipoxygenase enzymes during pollen season in nasal biopsies of pollen-allergic patients”. Allergy61 (6): 725–30. (June 2006). doi:10.1111/j.1398-9995.2006.00980.x. PMID16677242.
“The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache”. Pharmacol. Ther.120 (2): 157–71. (November 2008). doi:10.1016/j.pharmthera.2008.08.003. PMID18789357.
“Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency”. Mol. Genet. Metab.109 (3): 251–4. (July 2013). doi:10.1016/j.ymgme.2013.04.013. PMID23669167.
“Increased expression of arginase I and II in allergic nasal mucosa”. Laryngoscope121 (2): 236–40. (February 2011). doi:10.1002/lary.21288. PMID21271567.
“Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells”. Eur J Nutr52 (2): 505–12. (March 2013). doi:10.1007/s00394-012-0353-1. PMID22527286.
“Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress”. J. Nutr. Biochem.21 (5): 381–9. (May 2010). doi:10.1016/j.jnutbio.2009.01.011. PMID19423317.
“Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification”. Biochem. Biophys. Res. Commun.366 (4): 892–7. (February 2008). doi:10.1016/j.bbrc.2007.12.019. PMID18082622.
“Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial”. J. Neurol. Neurosurg. Psychiatry. (April 2018). doi:10.1136/jnnp-2018-317964. PMID29666206.
“Carnitine palmityltransferase II (CPT2) deficiency and migraine headache: two case reports”. Headache43 (5): 490–5. (May 2003). PMID12752755.
“The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis”. Biol Trace Elem Res150 (1-3): 42–8. (December 2012). doi:10.1007/s12011-012-9487-5. PMID22895810.
“Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache”. Cochrane Database Syst Rev (12): CD005219. (December 2015). doi:10.1002/14651858.CD005219.pub3. PMID26709672.
“High-flow oxygen therapy for treatment of acute migraine: A randomized crossover trial”. Cephalalgia37 (8): 730–736. (July 2017). doi:10.1177/0333102416651453. PMID27206964.
“Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial”. Am J Emerg Med30 (9): 1760–4. (November 2012). doi:10.1016/j.ajem.2012.02.010. PMID22560101.
“[14C]serine from phosphatidylserine labels ceramide and sphingomyelin in L929 cells: evidence for a new metabolic relationship between glycerophospholipids and sphingolipids”. Arch. Biochem. Biophys.410 (1): 107–11. (February 2003). PMID12559982.
“Metabolism and functions of glutathione in brain”. Prog. Neurobiol.62 (6): 649–71. (December 2000). PMID10880854.
“Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders”. Int. J. Neuropsychopharmacol.14 (1): 123–30. (February 2011). doi:10.1017/S1461145710000805. PMID20633320.
“A study of oxidative stress in migraine with special reference to prophylactic therapy”. Int. J. Neurosci.128 (4): 318–324. (April 2018). doi:10.1080/00207454.2017.1374959. PMID28903615.
“Oxidative stress in the airways of children with asthma and allergic rhinitis”. Pediatr Allergy Immunol23 (6): 556–61. (September 2012). doi:10.1111/j.1399-3038.2012.01294.x. PMID22435922.
“Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis”. Clin. Exp. Allergy33 (10): 1380–8. (October 2003). PMID14519144.
“Increased expression of lipoxygenase enzymes during pollen season in nasal biopsies of pollen-allergic patients”. Allergy61 (6): 725–30. (June 2006). doi:10.1111/j.1398-9995.2006.00980.x. PMID16677242.
“Antioxidant levels in the nasal mucosa of patients with chronic sinusitis and healthy controls”. Arch. Otolaryngol. Head Neck Surg.123 (2): 201–4. (February 1997). PMID9046290.
“Oxidative Stress and Low Glutathione in Common Ear, Nose, and Throat Conditions: A Systematic Review”. Altern Ther Health Med22 (5): 44–50. (September 2016). PMID27622960.
“The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache”. Pharmacol. Ther.120 (2): 157–71. (November 2008). doi:10.1016/j.pharmthera.2008.08.003. PMID18789357.
“Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency”. Mol. Genet. Metab.109 (3): 251–4. (July 2013). doi:10.1016/j.ymgme.2013.04.013. PMID23669167.
“Increased expression of arginase I and II in allergic nasal mucosa”. Laryngoscope121 (2): 236–40. (February 2011). doi:10.1002/lary.21288. PMID21271567.
“Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells”. Eur J Nutr52 (2): 505–12. (March 2013). doi:10.1007/s00394-012-0353-1. PMID22527286.
“Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress”. J. Nutr. Biochem.21 (5): 381–9. (May 2010). doi:10.1016/j.jnutbio.2009.01.011. PMID19423317.
“Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification”. Biochem. Biophys. Res. Commun.366 (4): 892–7. (February 2008). doi:10.1016/j.bbrc.2007.12.019. PMID18082622.